Meriaura Group Oyj
STO:MERIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Meriaura Group Oyj
STO:MERIS
|
FI |
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
HKBN Ltd
HKEX:1310
|
HK |
|
G
|
Genting Malaysia Bhd
OTC:GMALY
|
MY |
|
E
|
Erection Electromechanics Testing JSC
VN:LCD
|
VN |
|
C
|
Com2uSCorp
KOSDAQ:078340
|
KR |
|
Z
|
Zions Bancorporation NA
NASDAQ:ZION
|
US |
|
Giyani Metals Corp
XTSX:EMM
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MERIS's stock price target?
Not Available
MERIS doesn't have any price targets made by Wall Street professionals.
What is Meriaura Group Oyj's Revenue forecast?
Projected CAGR
1%
For the last 4 years the compound annual growth rate for Meriaura Group Oyj's revenue is 152%. The projected CAGR for the next 2 years is 1%.